ATS 2019 Virtual Final Program

Facilitator : D.G. Chapman, BSc, PhD, Glebe, Australia P619 Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies/ J.A. Ohar, A. Ozol-Godfrey, T. Goodin, S. Sanjar, Winston-Salem, NC, p.A3869 P620 Effect of Metabolic Syndrome Status on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies/ B. Carlin, G.T. Ferguson, A. Ozol-Godfrey, T. Goodin, S. Sanjar, Pittsburgh, PA, p.A3870 P621 Use of a Comorbidity Count to Assess the Prevalence of Comorbidities in the GOLDEN 3 and 4 Randomized Clinical Trials in Patients with Moderate-to-Very-Severe COPD/ S. Sharma, T. Goodin, A. Ozol-Godfrey, S. Sanjar, Marlborough, MA, p.A3871 P622 Reduced Sleep Quality Correlates with Worse Hyperinflation in Patients with Chronic Obstructive Pulmonary Disease/ D. Chapman, K. Jetmalani, C. Thamrin, C.S. Farah, R.R. Grunstein, M. Comas-Soberats, P.M. Young, C.L. Phillips, G. King, Sydney, Australia, p.A3872 P623 The Effect of Baseline Rescue Medication Use on Lung Function and Patient-Reported Outcomes in Patients with COPD Treated with Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies/ J.F. Donohue, A. Ozol-Godfrey, T. Goodin, S. Sanjar, Chapel Hill, NC, p.A3873 P624 Improvement in Lung Function and Patient-Reported Outcomes in Patients with Chronic Obstructive Pulmonary Disease with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies/ N.A. Hanania, A. Ozol-Godfrey, M. Tocco, T. Goodin, S. Sanjar, Houston, TX, p.A3874 P625 The Impact of Missing Spirometry Data in the GOLDEN 3 and 4 Studies of Patients with Moderate-to-Very-Severe COPD Treated with Nebulized Glycopyrrolate/ R. Tosiello, R. Claus, A. Ozol-Godfrey, K. Whicher, R. Carroll, G. Vega, T. Goodin, Marlborough, MA, p.A3875 Facilitator : G. Ruffenach, PhD, MSc, Los Angeles, CA P626 Feasibility of Longitudinal Emphysema Measurements in COPD and Alpha-1 Antitrypsin Deficiency Using 3He and 129Xe MRI/ A.V. Ouriadov, A.R. Westcott, D.G. McCormack, G. Parraga, London, Canada, p.A3876 P627 Predictors and Impact of Pneumothorax on Patients of Chronic Obstructive Pulmonary Disease Exacerbation: A Study from National Inpatient Sample/ A. Wahab, A. Abdullah, G. Eigbire, A. Salama, R. Alweis, Rochester, NY, p.A3877 P628 Virtual Bronchoscopy Navigation (VBN) Planning for Bronchoscopic Lung Volume Reduction (BLVR)/ J.A. Ramzy, J. Thomas, H. Criner, M. Basile, C.A. Dass, N. Marchetti, G.J. Criner, Philadelphia, PA, p.A3878 P629 A Genome Wide Association Study for Lung Function in Korean Population Using Exome Array/ K.S. Lee, W. Kim, B. Han, Chuncheon-si, Korea, Republic of, p.A3879 P630 Effects of Glycopyrronium Bromide (GB) Delivered Via a Pressurized Metered-Dose Inhaler (pMDI) in Subjects with Chronic Obstructive Pulmonary Disease (COPD) on Cardiovascular Parameters: Results from the GLIMMER Study/ E.M. Kerwin, G. Feldman, C. Beaudot, G. Georges, Medford, OR, p.A7371 P631 Pulmonary Arterial Enlargement Is Associated with COPD and CHF Hospital Admission in a Large CT Lung Screening Cohort/ W. Thedinger, P.S. Shah, A. Damla, C. Stefanescu, M. Gawlik, A. Sanayei, W. Long, G. Rizzo, S. Regis, A.B. McKee, B.J. McKee, C. Wald, G.R. Washko, R. San Jose Estepar, L. Gazourian, Boston, MA, p.A7372 P632 Deficient Muscle Regeneration Potential in Sarcopenic COPD Patients: Role of Satellite Cells/ E. Barreiro, A. Sancho-Muñoz, M. Guitart, K. Ihnatsiuk, J. Gea, D.A. Rodriguez, J. Martinez-Llorens, BARCELONA, Spain, p.A7373 BASIC • BEHAVIORAL THEMATIC POSTER SESSION B65 SRN: DIAGNOSIS AND MONITORING OF SLEEP AND SLEEP DISORDERS 9:15 a.m. - 4:15 p.m. KBHCCD Area K (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : H.-L. Tan, MBBS, London, United Kingdom P1213 Assessment of Upper Airway Collapse in Obstructive Sleep Apnea Patients by Awake Müller’s Maneuver: Reproducibility and Comparison with Drug-Induced Sleep Endoscopy/ E. Van de Perck, S. Op de Beeck, M. Dieltjens, A.E. Verbruggen, A.V. Vroegop, P.H. Van de Heyning, M.J. Braem, O.M. Vanderveken, Edegem, Belgium, p.A3880 P1214 Diagnostic Accuracy of the STOP-BANG Questionnaire and the EPWORTH SLEEPINESS SCALE in Detecting Obstructive Sleep Apnea in Bariatric Surgery Candidates/ S.M. Hassan, A. Mubarik, W. Burney, S.A. Khan, M. Qasim, M. Basit, F. Haq, F.N. Rahaghi, S. Muddassir, Salem, MA, p.A3881 P1215 Translation and Validation of Vietnamese Version of STOP-Bang Questionnaire/ K.D. Duong, V.T. Le, V.N. Nguyen, H. Hoang, G.V. Vu, N.V. Tran, Ho Chi Minh City, Viet Nam, p.A3882 P1216 Investigating Sleep Disorders: Are We Able to Target the Right Population?/ J. Ibrahim, A. Ali, M.Z. Khan, M. Radzali, E. Crawford, A. Makan, N. Ahmad, K. Srinivasan, H. Moudgil, Telford, United Kingdom, p.A3883 P1217 Using a Sedation Monitor to Assess Sleep/ C. Kapp, N.M. Punjabi, Baltimore, MD, p.A3884 ATS 2019 • Dallas, TX MONDAY • MAY 20 185 MONDAY MORNING